SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies ...

March 28, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces two poster presentations at the European Society for ...

Dec. 9, 2024 — A NASA Hubble Space Telescope observation program called OPAL (Outer Planet Atmospheres Legacy) obtains long-term baseline observations of Jupiter, Saturn, Uranus, and Neptune in ...

Two posters will highlight new data from the company’s open-label ASCENT study of LIQ861 (YUTREPIA) in PH-ILD patients with a focus on safety, tolerability, exploratory changes in 6-minute walk ...

today announced four preclinical poster presentations at the upcoming 2025 AACR Annual Meeting being held in Chicago, IL April 25-30, 2025.

Gain Therapeutics' lead drug candidate, GT-02287, is in clinical development for the treatment of Parkinson's disease (PD) with or without a GBA1 mutation. The orally administered, brain-penetrant ...

Two posters will highlight new data from the company's open-label ASCENT study of LIQ861 (YUTREPIA) in PH-ILD patients with a focus on safety, tolerability, exploratory changes in 6-minute walk ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

Election sign orders are streaming in at TR Trades Reproduction, a family-owned printing business in Kitsilano. Their most recent run was 35 signs for a local Green candidate running in the ...